Tomas Hajek1,2, Katja Franke3, Marian Kolenic2, Jana Capkova2, Martin Matejka2,4, Lukas Propper1, Rudolf Uher1, Pavla Stopkova2, Tomas Novak2, Tomas Paus5,6, Miloslav Kopecek2, Filip Spaniel2, Martin Alda1,2. 1. Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. 2. National Institute of Mental Health, Klecany, Czech Republic. 3. Structural Brain Mapping Group, Department of Neurology, Jena University Hospital, Jena, Germany. 4. Psychiatric Hospital Bohnice, Prague, Czech Republic. 5. Rotman Research Institute and Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON, Canada. 6. Center for Developing Brain, Child Mind Institute, New York, NY.
Abstract
Background: The greater presence of neurodevelopmental antecedants may differentiate schizophrenia from bipolar disorders (BD). Machine learning/pattern recognition allows us to estimate the biological age of the brain from structural magnetic resonance imaging scans (MRI). The discrepancy between brain and chronological age could contribute to early detection and differentiation of BD and schizophrenia. Methods: We estimated brain age in 2 studies focusing on early stages of schizophrenia or BD. In the first study, we recruited 43 participants with first episode of schizophrenia-spectrum disorders (FES) and 43 controls. In the second study, we included 96 offspring of bipolar parents (48 unaffected, 48 affected) and 60 controls. We used relevance vector regression trained on an independent sample of 504 controls to estimate the brain age of study participants from structural MRI. We calculated the brain-age gap estimate (BrainAGE) score by subtracting the chronological age from the brain age. Results: Participants with FES had higher BrainAGE scores than controls (F(1, 83) = 8.79, corrected P = .008, Cohen's d = 0.64). Their brain age was on average 2.64 ± 4.15 years greater than their chronological age (matched t(42) = 4.36, P < .001). In contrast, participants at risk or in the early stages of BD showed comparable BrainAGE scores to controls (F(2,149) = 1.04, corrected P = .70, η2 = 0.01) and comparable brain and chronological age. Conclusions: Early stages of schizophrenia, but not early stages of BD, were associated with advanced BrainAGE scores. Participants with FES showed neurostructural alterations, which made their brains appear 2.64 years older than their chronological age. BrainAGE scores could aid in early differential diagnosis between BD and schizophrenia.
Background: The greater presence of neurodevelopmental antecedants may differentiate schizophrenia from bipolar disorders (BD). Machine learning/pattern recognition allows us to estimate the biological age of the brain from structural magnetic resonance imaging scans (MRI). The discrepancy between brain and chronological age could contribute to early detection and differentiation of BD and schizophrenia. Methods: We estimated brain age in 2 studies focusing on early stages of schizophrenia or BD. In the first study, we recruited 43 participants with first episode of schizophrenia-spectrum disorders (FES) and 43 controls. In the second study, we included 96 offspring of bipolar parents (48 unaffected, 48 affected) and 60 controls. We used relevance vector regression trained on an independent sample of 504 controls to estimate the brain age of study participants from structural MRI. We calculated the brain-age gap estimate (BrainAGE) score by subtracting the chronological age from the brain age. Results:Participants with FES had higher BrainAGE scores than controls (F(1, 83) = 8.79, corrected P = .008, Cohen's d = 0.64). Their brain age was on average 2.64 ± 4.15 years greater than their chronological age (matched t(42) = 4.36, P < .001). In contrast, participants at risk or in the early stages of BD showed comparable BrainAGE scores to controls (F(2,149) = 1.04, corrected P = .70, η2 = 0.01) and comparable brain and chronological age. Conclusions: Early stages of schizophrenia, but not early stages of BD, were associated with advanced BrainAGE scores. Participants with FES showed neurostructural alterations, which made their brains appear 2.64 years older than their chronological age. BrainAGE scores could aid in early differential diagnosis between BD and schizophrenia.
Authors: Igor Nenadić; Maren Dietzek; Kerstin Langbein; Heinrich Sauer; Christian Gaser Journal: Psychiatry Res Neuroimaging Date: 2017-05-24 Impact factor: 2.376
Authors: Karestan C Koenen; Terrie E Moffitt; Andrea L Roberts; Laurie T Martin; Laura Kubzansky; HonaLee Harrington; Richie Poulton; Avshalom Caspi Journal: Am J Psychiatry Date: 2008-12-01 Impact factor: 18.112
Authors: D P Hibar; L T Westlye; N T Doan; N Jahanshad; J W Cheung; C R K Ching; A Versace; A C Bilderbeck; A Uhlmann; B Mwangi; B Krämer; B Overs; C B Hartberg; C Abé; D Dima; D Grotegerd; E Sprooten; E Bøen; E Jimenez; F M Howells; G Delvecchio; H Temmingh; J Starke; J R C Almeida; J M Goikolea; J Houenou; L M Beard; L Rauer; L Abramovic; M Bonnin; M F Ponteduro; M Keil; M M Rive; N Yao; N Yalin; P Najt; P G Rosa; R Redlich; S Trost; S Hagenaars; S C Fears; S Alonso-Lana; T G M van Erp; T Nickson; T M Chaim-Avancini; T B Meier; T Elvsåshagen; U K Haukvik; W H Lee; A H Schene; A J Lloyd; A H Young; A Nugent; A M Dale; A Pfennig; A M McIntosh; B Lafer; B T Baune; C J Ekman; C A Zarate; C E Bearden; C Henry; C Simhandl; C McDonald; C Bourne; D J Stein; D H Wolf; D M Cannon; D C Glahn; D J Veltman; E Pomarol-Clotet; E Vieta; E J Canales-Rodriguez; F G Nery; F L S Duran; G F Busatto; G Roberts; G D Pearlson; G M Goodwin; H Kugel; H C Whalley; H G Ruhe; J C Soares; J M Fullerton; J K Rybakowski; J Savitz; K T Chaim; M Fatjó-Vilas; M G Soeiro-de-Souza; M P Boks; M V Zanetti; M C G Otaduy; M S Schaufelberger; M Alda; M Ingvar; M L Phillips; M J Kempton; M Bauer; M Landén; N S Lawrence; N E M van Haren; N R Horn; N B Freimer; O Gruber; P R Schofield; P B Mitchell; R S Kahn; R Lenroot; R Machado-Vieira; R A Ophoff; S Sarró; S Frangou; T D Satterthwaite; T Hajek; U Dannlowski; U F Malt; V Arolt; W F Gattaz; W C Drevets; X Caseras; I Agartz; P M Thompson; O A Andreassen Journal: Mol Psychiatry Date: 2017-05-02 Impact factor: 15.992
Authors: Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard Journal: Psychoneuroendocrinology Date: 2019-04-05 Impact factor: 4.905
Authors: Saba Shahab; Benoit H Mulsant; Melissa L Levesque; Navona Calarco; Arash Nazeri; Anne L Wheeler; George Foussias; Tarek K Rajji; Aristotle N Voineskos Journal: Neuropsychopharmacology Date: 2018-12-20 Impact factor: 7.853
Authors: Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello Journal: Neuropsychopharmacology Date: 2020-09-12 Impact factor: 7.853
Authors: Won Hee Lee; Mathilde Antoniades; Hugo G Schnack; Rene S Kahn; Sophia Frangou Journal: Psychiatry Res Neuroimaging Date: 2021-03-05 Impact factor: 2.376
Authors: Rachel M Brouwer; Jelle Schutte; Ronald Janssen; Dorret I Boomsma; Hilleke E Hulshoff Pol; Hugo G Schnack Journal: Cereb Cortex Date: 2021-01-05 Impact factor: 5.357